Amniox Medical, Inc., a developer and marketer of restorative therapies processed from amniotic membrane and umbilical cord, announces the initiation of a randomized, controlled clinical trial of its proprietary product in patients with chronic wounds.
from Content Keyword RSS http://ift.tt/1tW5qtC
via IFTTT
from Content Keyword RSS http://ift.tt/1tW5qtC
via IFTTT
No comments:
Post a Comment